Glomerular crescents

Last updated on: 21.08.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Glomerular crescents is the appearance of a histopathological lesion with extracapillary proliferation in the glomeruli (Jung 2020).

It is a hyperplastic lesion that may account for 10% or more of the circumference of Bowman's capsule (Anguiano 2020).

ClassificationThis section has been translated automatically.

One differentiates, depending on the composition between:

- Cellular crescent

Here 75% cells and fibrin are found and less than 25% fibrous matrix.

- Fibrocellular crescent

This is characterized by 25-75% cells and fibrin, with the remainder fibrous matrix.

- Fibrous crescent

This is characterized by 75% fibrous matrix with less than 25% cells or fibrin (Anguiano 2020).

EtiologyThis section has been translated automatically.

Glomerular crescents can occur in a variety of glomerular diseases, collectively known as crescentic glomerulonephritis (CGN) such as:

- Rapid progressive glomerulonephritis (RPGN) (Young 2020).

- mesangioproliferative gl omerulonephritis with diffuse crescent formation (MESPGN- DH), also referred to as "idiopathic crescent glomerulonephritis"

- glomerulonephritis in Schönlein- Henoch purpura (Remmele 1984)

- anti-glomerular basement membrane disease (McAdoo 2017).

PathophysiologyThis section has been translated automatically.

Cellular crescents develop from activated parietal epithelial cells (PECs). There are several molecular pathways that trigger this activation. These include, for example, microvascular injury leading to rupture of the glomerular basement membrane, resulting in leakage of plasma proteins with hyperplasia of parietal epithelial cells (Anguiano 2020).

The crescents are located along the Bowman capsule. Due to its formation, there is a decrease in glomerular filtration rate.

The cellular crescents are still reversible at an early stage. However, as soon as the multistage growth of activated parietal epithelial cells is accompanied by a change in cell phenotype and fibrous crescents form, they are irreversible (Anguiano 2020).

Glomerular crescents are thus usually the result of an intense immune attack involving cytotoxic elements (Anguiano 2020).

HistologyThis section has been translated automatically.

Glomerular crescents are found on histologic examination as extracapillary proliferative foci in various glomerular diseases of the kidney (Jung 2020).

They consist of a variable mixture of cells, fibrin, and fibrous matrix (Anguiano 2020) and are designated differently, depending on their composition (see "Classification").

TherapyThis section has been translated automatically.

In a study using a mouse model, Melica et al. (2022) showed that panobinostat administration reduced the number of crescent formation and showed significant improvement in renal function including proteinuria.

Panobinostat has previously been used to treat hematopoietic stem cell disorders (Melica 2022).

PrognoseThis section has been translated automatically.

Disease in which more than 50% of the glomeruli show crescents is associated with a poor prognosis in terms of renal function and patient survival (Melica 2022).

LiteratureThis section has been translated automatically.

  1. Anguiano L, Kain R, Anders H J (2020) The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hytertens. 29 (3) 302 - 309
  2. Herold G et al (2022) Internal medicine. Herold Publishers 609
  3. Jung N, Mayet W J, Mertens P R, Meyer J, Müller O A (2020) Rational diagnosis and therapy in internal medicine: guideline-based recommendations for practice. Elsevier Urban and Fischer Publishers Munich 3
  4. Kasper D L, Fauci A S, Hauser S L, Longo D L, Jameson J L, Loscalzo J et al (2015) Harrison's Principles of Internal Medicine. Mc Graw Hill Education
  5. McAdoo S P, Pusey C D (2017) Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 12 (7) 1162 - 1172.
  6. Melica M E, Antonelli G, Semeraro R, Angelotti M L, Ludgi G, Landini S, Ravaglia F, la Regina G, Conte C, de Chiara L, Peired A J, Mazzinghi B. Donati M, Molli A, Steiger S, Magi A, Bartalucci N, Raglianti V, Guzzi F, Maggi L, Annunziato F, Burger A, Lazzeri E, Anders H J, Lassagni L, Romagnani P (2022) Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice. Sci Transl Med. 14 (657) eabg 3277.
  7. Remmele W, Bässler R, Böcker W, Dallenbach- Hellweg G, Delling G, Harms D, Klöppel G, Mohr W, Müntefering H, Saeger W, Scherer R, Schubert G E, Städtler F, Vogel, M, Wolff H H (1984) Pathology: genitourinary organs, mammary, endocrine organs, pediatric pathology, musculoskeletal system (except musculature), skin. Springer Verlag Berlin / Heidelberg / New York / Tokyo 74

Last updated on: 21.08.2023